|
|
1)
|
Looking at 'Identification of Practices Associated with HIV Prevention and Treatment':
PrEP [Pre-Exposure Prophylaxis] is a biomedical intervention in which people at risk for contracting HIV adhere to a regimen of daily oral antiretroviral medications to prevent contracting the virus if exposed to it.
|
|
True
False
|
|
2)
|
PrEP programs are for those who do not have HIV but are considered AT RISK, which includes
|
|
|
|
3)
|
PrEP is approximately _____ percent effective at preventing HIV when taken consistently to maintain uptake into the bloodstream.
|
|
|
|
4)
|
After an at-risk person has begun the PrEP HIV prevention program, psychosocial supports are not often required because those taking PrEP know how effective the drug is in preventing HIV.
|
|
True
False
|
|
5)
|
PrEP is the only intervention known to be effective in prevention of HIV in persons with a dual diagnosis of SUD and Mental Illness.
|
|
True
False
|
|
6)
|
What is NOT an essential activity or service provided by PrEP programs?
|
|
|
|
7)
|
In this document, SSP refers to __________for people who inject drugs (PWID).
|
|
|
|
8)
|
Decades of research demonstrate ___________ evidence for the efficacy and importance of SSPs in reducing the transmission of infectious diseases, including HIV and hepatitis C virus (HCV).
|
|
|
|
9)
|
What is not true about SSPs?
|
|
|
|
10)
|
Sterile syringes can be provided in fixed and mobile settings, by pharmacists, pharmacy managers, clerks, and technicians dispensing over-the-counter syringes, outreach workers, and trained volunteers and healthcare professionals.
.
|
|
True
False
|
|
11)
|
Which circumstance below is not identified as a major BARRIER to the effectiveness of sterile syringe programs?
|
|
|
|
12)
|
SSPs can provide sterile syringes in single or multiple day supplies, based on the number of syringes returned and the reported injection frequency.
|
|
True
False
|
|
13)
|
What is not true about CONTINGENCY MANAGEMENT (CM) in HIV prevention and treatment programs?
|
|
|
|
14)
|
OUTCOMES ASSOCIATED WITH Cognitive Behavioral Therapy (CBT) in HIV programs: Which outcomes have been demonstrated?
|
|
|
|
15)
|
INTENSITY AND DURATION of CBT: What is not true about the effective use of CBT in HIV prevention and treatment?
|
|
|
|
16)
|
In the context of the HIV-care continuum, PATIENT NAVIGATION services typically focus on linkage to and retention in care, improving HIV treatment outcomes, client satisfaction, and client self-management.
|
|
True
False
|
|
17)
|
Patient Navigation services have had little success with men and transgender women transitioning from jail and prison to the community.
|
|
True
False
|
|
18)
|
Moving to Chapter 3, IMPLEMENTATION CHALLENGES AND STRATEGIES: What is NOT true about the challenges and strategies of setting up an effective HIV program for persons with a dual diagnosis of SUD or Mental Illness?
|
|
|
When adapting a current program to provide an effective HIV Harm Reduction Model, we should strive to preserve the setting of the current program (e.g., outpatient clinic, mobile health unit, walk-in clinic, etc.)
|
|
We should engage existing and potential clients in project planning, practice selection, and materials development.
|
|
Competent staff may need special training to create a culturally appropriate, nonjudgmental, welcoming, and non-stigmatizing Harm Reduction environment.
|
|
The complex medical comorbidities of dually diagnosed people with or at risk for HIV require careful coordination, collaboration, and communication between SUD, Mental Health, HIV, and medical program staff.
|
|
Most mental health and SUD programs should implement the models described in this course without modification or adaptation.
|
|
|
19)
|
Clients who receive treatment in HIV programs that screen for mental illness and SUD and provide coordinated care to address all three issues are MORE LIKELY to reach HIV viral suppression, than are clients who receive treatment in HIV primary care services WITHOUT coordinated mental health and SUD services.
|
|
True
False
|
|
20)
|
On page 34 of this Study Guide 2, you will find a link to the 'Guide to Developing and Managing Syringe Access Programs', published by the Harm Reduction Coalition.
|
|
True
False
|
|